{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T05:41:51Z","timestamp":1789537311991,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,4]],"date-time":"2014-09-04T00:00:00Z","timestamp":1409788800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2334-14-479","type":"journal-article","created":{"date-parts":[[2014,9,4]],"date-time":"2014-09-04T15:34:23Z","timestamp":1409844863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Molecular detection and characterization of resistant genes in Mycobacterium tuberculosis complex from DNA isolated from tuberculosis patients in the Eastern Cape province South Africa"],"prefix":"10.1186","volume":"14","author":[{"given":"Nolwazi L","family":"Bhembe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uchechukwu U","family":"Nwodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharlene","family":"Govender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland N","family":"Ndip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony I","family":"Okoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezekiel","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,4]]},"reference":[{"key":"3784_CR1","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1073\/pnas.052548299","volume":"99","author":"R Brosch","year":"2002","unstructured":"Brosch R, Gordon SV, Marmiesse M, Brodin P, Buchrieser C, Eiglmeir K: A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A. 2002, 99: 3684-3689. 10.1073\/pnas.052548299.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3784_CR2","first-page":"481","volume":"27","author":"HP Riemann","year":"1983","unstructured":"Riemann HP, Abbas B: Diagnosis and control of bovine paratuberculosis (Johne\u2019s disease). Adv Vet Sci Med. 1983, 27: 481-503.","journal-title":"Adv Vet Sci Med"},{"key":"3784_CR3","first-page":"248","volume-title":"South African Health Review","author":"C Day","year":"2005","unstructured":"Day C, Gray A: Health and related indicators. Chapter 17. South African Health Review. Edited by: Ijumba P, Barron P. 2005, South Africa: Health Systems Trust Durban, 248-367. 10","edition":"10"},{"key":"3784_CR4","volume-title":"Global tuberculosis control","author":"World Health Organization","year":"2010","unstructured":"World Health Organization: Global tuberculosis control. 2010, Geneva: WHO report, http:\/\/reliefweb.int\/sites\/reliefweb.int\/files\/resources\/F530290AD0279399C12577D8003E9D65-Full_Report.pdf,"},{"key":"3784_CR5","volume-title":"Seventh meeting of the Strategic and Technical Advisory Group for Tuberculosis (STAG-TB): report on conclusions and recommendations","author":"WHO","year":"2007","unstructured":"WHO: Seventh meeting of the Strategic and Technical Advisory Group for Tuberculosis (STAG-TB): report on conclusions and recommendations. 2007, Geneva: World Health Organization"},{"key":"3784_CR6","unstructured":"World Health Organization: World Health Organisation. Organization: Tuberculosis and Gender Accessed at http:\/\/www.who.int\/tb\/challenges\/gender\/en (Accessed 11 November 2013)"},{"key":"3784_CR7","unstructured":"Statistical Release. [http:\/\/www.statssa.gov.za\/publications\/P03014\/P030142011.pdf] (Accessed 09 October 2013)"},{"key":"3784_CR8","first-page":"68","volume":"29","author":"FA Kaona","year":"2004","unstructured":"Kaona FA, Tuba M, Siziya S, Sikaona L: An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. Public Health. 2004, 29: 68-","journal-title":"Public Health"},{"key":"3784_CR9","unstructured":"Global Alliance for TB Drug Development. [http:\/\/www.tballiance.org\/why\/mdr-xdr.php] (Accessed 27 August 2013)"},{"key":"3784_CR10","unstructured":"World health Organization. [http:\/\/www.who.int\/tb\/publications\/global_report\/] (Accessed 12 December 2013)"},{"issue":"2","key":"3784_CR11","first-page":"022","volume":"2","author":"D Olusoji","year":"2013","unstructured":"Olusoji D, Eltayeb O, Olanrewaju O, Olapade GD: Pre-extensive drug resistant tuberculosis (pre-XDR-TB) among MDR-TB patents in Nigeria. Glob Advanc Res J Microbiol. 2013, 2 (2): 022-025.","journal-title":"Glob Advanc Res J Microbiol"},{"key":"3784_CR12","first-page":"117","volume":"22","author":"A Nawaz","year":"2012","unstructured":"Nawaz A, Chaudhry ZI, Shahid M, Gul S, Khan FA, Hussain M: Detection of Mycobacterium tuberculosis and Mycobacterium bovisin sputum and blood samples of human. J Agr Sci. 2012, 22: 117-120.","journal-title":"J Agr Sci"},{"key":"3784_CR13","first-page":"891","volume-title":"Manual of Clinical Microbiology. Volume 38","author":"A Balows","year":"2001","unstructured":"Balows A, Hausler WJ, Jr Herrmann KL: Society for microbiology. Manual of Clinical Microbiology. Volume 38. Edited by: Isenberg HD, Shadomy HJ. 2001, Washington, DC, 891-894. doi:10.1111\/j.1348-0421.1994.tb02142.x, 5","edition":"5"},{"issue":"1","key":"3784_CR14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1128\/JCM.00750-06","volume":"45","author":"J Sekiguchi","year":"2007","unstructured":"Sekiguchi J, Miyoshi-Akiyama T, Augustynowicz-Kope\u0107 E, Zwolska Z, Kirikae F, Toyota E: Detection of multidrug resistance in Mycobacterium tuberculosis. J Clin Microbiol. 2007, 45 (1): 179-192. 10.1128\/JCM.00750-06.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"3784_CR15","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1093\/molbev\/msr121","volume":"28","author":"K Tamura","year":"2011","unstructured":"Tamura K, Peterson D, Peterson N, Strecher G, Nei M, Kumar S: MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsiomony methods. Mol Biol Evol. 2011, 28 (10): 2731-2739. 10.1093\/molbev\/msr121.","journal-title":"Mol Biol Evol"},{"key":"3784_CR16","unstructured":"Statistics South Africa. [http:\/\/beta2.statssa.gov.za\/?page_id=1021&id=buffalo-city-municipality] (Accessed 28 August 2013)"},{"key":"3784_CR17","first-page":"381","volume":"10","author":"DA Onifade","year":"2010","unstructured":"Onifade DA, Bayer AM, Mantoya R, Haro M, Alva J, Franco J: Gender-related factors influencing tuberculosis control in Shanty towns: qualitative study. BMC BioMed. 2010, 10: 381-","journal-title":"BMC BioMed"},{"key":"3784_CR18","first-page":"6","volume":"65","author":"CJL Murray","year":"1990","unstructured":"Murray CJL, Styblo K, Rouillon A: Tuberculosis in developing countries: burden, intervention and cost. Int J Tuberc Lung Dis. 1990, 65: 6-24.","journal-title":"Int J Tuberc Lung Dis"},{"key":"3784_CR19","first-page":"213","volume":"153","author":"I Moskrousovi","year":"2002","unstructured":"Moskrousovi I, Filliol I, Legrand E, Sola C, Otten T, Vyshnevskaya E: Molecular characterization of multiple-drug-resistant Mycobacterium tuberculosis isolates from north-western Russia and analysis of rifampin resistance using RNA\/RNA mismatch analysis as compared to the line probe assay and sequencing of the rpoB gene. J Microbiol. 2002, 153: 213-219.","journal-title":"J Microbiol"},{"issue":"11","key":"3784_CR20","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1128\/JCM.39.11.4131-4137.2001","volume":"39","author":"H EL-Hajji","year":"2001","unstructured":"EL-Hajji H, Marras SAE, Tyagi S, Kramer FR, Alland D: Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons. J Clin Microbiol. 2001, 39 (11): 4131-4137. 10.1128\/JCM.39.11.4131-4137.2001.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"3784_CR21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/rr54","volume":"2","author":"A Somoskovi","year":"2001","unstructured":"Somoskovi A, Parsons LM, Salfinger M: The molecular basis of resistance to isoniazid, rifampin and pyrazinamide in Mycobacterium tuberculosis. Respi Res. 2001, 2 (3): 164-168. 10.1186\/rr54.","journal-title":"Respi Res"},{"issue":"1","key":"3784_CR22","first-page":"7","volume":"28","author":"E Green","year":"2010","unstructured":"Green E, Obi L, Nchabeleng M, de Villiers BE, Sein PP, Letsoalo T: Drug-susceptibility patterns of Mycobacterium tuberculosis in Mpumalanga Province, South Africa: possible guiding design of retreatment regimen. J Health Popul Nutr. 2010, 28 (1): 7-13.","journal-title":"J Health Popul Nutr"},{"key":"3784_CR23","first-page":"6","volume":"235190","author":"A Otu","year":"2013","unstructured":"Otu A, Umoh V, Habib A, Soter Ameh S, Lawson L, Ansa V: Drug resistance among pulmonary tuberculosis patients in Calabar, Nigeria. Pulm Med. 2013, 235190: 6-","journal-title":"Pulm Med"},{"issue":"1","key":"3784_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0012-3692(15)50981-1","volume":"130","author":"SK Sharma","year":"2006","unstructured":"Sharma SK, Mohan A: Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control. Chest. 2006, 130 (1): 261-272.","journal-title":"Chest"},{"issue":"5562","key":"3784_CR25","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1126\/science.1063814","volume":"295","author":"C Dye","year":"2002","unstructured":"Dye C, Williams BG, Espinal MA, Raviglione MC: Erasing the world\u2019s slow stain: strategies to beat multidrug-resistant tuberculosis. Science. 2002, 295 (5562): 2042-2046. 10.1126\/science.1063814.","journal-title":"Science"},{"issue":"9343","key":"3784_CR26","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/S0140-6736(02)11401-2","volume":"360","author":"B Amadi","year":"2002","unstructured":"Amadi B, Mwiya M, Musuku J, Watuka A, Sianongo S, Ayoub A: Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet. 2002, 360 (9343): 1375-1380. 10.1016\/S0140-6736(02)11401-2.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"3784_CR27","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1097\/00126334-200010001-00006","volume":"25","author":"SM Arpadi","year":"2000","unstructured":"Arpadi SM: Growth failure in children with HIV infection. J Acquir Immune Defic Syndr. 2000, 25 (Suppl 1): S37-S42.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"3784_CR28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/gut.45.1.70","volume":"45","author":"D Sharpstone","year":"1999","unstructured":"Sharpstone D, Neild P, Crane R, Taylor C, Hodgson C, Sherwood R: Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea. Gut. 1999, 45 (1): 70-76. 10.1136\/gut.45.1.70.","journal-title":"Gut"},{"key":"3784_CR29","unstructured":"World Health Organization. [http:\/\/www.who.int\/nutrition\/topics\/PN1_Macronutrients_Durban.pdf] (Accessed 10 March 2014)"},{"issue":"5","key":"3784_CR30","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1056\/NEJM199502023320518","volume":"332","author":"KB Patel","year":"1995","unstructured":"Patel KB, Belmonte R, Crowe HM: Drug malabsorption and resistant tuberculosis in HIV-infected patients. N Engl J Med. 1995, 332 (5): 336-337.","journal-title":"N Engl J Med"},{"issue":"3","key":"3784_CR31","first-page":"220","volume":"1","author":"D Anastasis","year":"1997","unstructured":"Anastasis D, Pillai G, Rambiritch V, Abdool Karim SS: A retrospective study of human immunodeficiency virus infection and drug-resistant tuberculosis in Durban, South Africa. Int J Tuberc Lung Dis. 1997, 1 (3): 220-224.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"7","key":"3784_CR32","first-page":"903","volume":"87","author":"FA Post","year":"1997","unstructured":"Post FA, Wood R: HIV infection is not associated with an increased rate of drug-resistant tuberculosis. S Afr Med. 1997, 87 (7): 903-","journal-title":"S Afr Med"},{"issue":"4","key":"3784_CR33","first-page":"381","volume":"90","author":"J Murray","year":"2000","unstructured":"Murray J, Sonnenberg P, Shearer S, Godfrey-Faussett P: Drug-resistant pulmonary tuberculosis in a cohort of Southern African goldminers with a high prevalence of HIV infection. S Afr Med. 2000, 90 (4): 381-386.","journal-title":"S Afr Med"},{"issue":"5","key":"3784_CR34","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1128\/AAC.01550-10","volume":"55","author":"PJ Campbell","year":"2011","unstructured":"Campbell PJ, Morlock GP, Sikes RD, Dalton TL, Netchock B, Starks AM: Molecular detection of mutations associated with first- and second line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2011, 55 (5): 2032-2041. 10.1128\/AAC.01550-10.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"3784_CR35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/10158782.2008.11441316","volume":"23","author":"E Green","year":"2008","unstructured":"Green E, Obi LC, Nchabeleng M, de Villiers BE, Sein PP, Letsoalo T: Molecular characterisation of resistant Mycobacterium tuberculosis isolates from Dr George Mukhari Hospital, Pretoria, South Africa. South Afr J Epidemiol Infect. 2008, 23 (3): 11-14.","journal-title":"South Afr J Epidemiol Infect"},{"key":"3784_CR36","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1128\/JCM.39.4.1591-1594.2001","volume":"39","author":"HR Van Doorn","year":"2001","unstructured":"Van Doorn HR, Kuijper EJ, Van der Ende A: The susceptibility of Mycobacterium tuberculosis to isoniazid and the Arg to Leu mutation at codon 463 of katG are not associated. J Clin Microbiol. 2001, 39: 1591-1594. 10.1128\/JCM.39.4.1591-1594.2001.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"3784_CR37","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1128\/AAC.47.6.2009-2011.2003","volume":"47","author":"D Bokonyte","year":"2003","unstructured":"Bokonyte D, Baranauskaie A, Gcenaite J, Sosnovkaja A, Stakenas P: Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania. Antimicrob Agents Chemother. 2003, 47 (6): 2009-2011. 10.1128\/AAC.47.6.2009-2011.2003.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3784_CR38","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1128\/AAC.49.1.144-147.2005","volume":"49","author":"L Herrera-Leon","year":"2005","unstructured":"Herrera-Leon L, Molina T, Saiz P, Saez-Nieto JA, Jimenez MS: New multiplex PCR for rapid detection of isoniazid-resistant Mycobacterium tuberculosis clinical isolates. Antimicrob Agents Chemother. 2005, 49 (1): 144-147. 10.1128\/AAC.49.1.144-147.2005.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"3784_CR39","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1128\/AAC.41.7.1601","volume":"41","author":"WH Haas","year":"1997","unstructured":"Haas WH, Schilke K, Brand J, Amthor B, Weyer K, Fourie B: Molecular Analysis of katG Gene Mutations in Strains of Mycobacterium tuberculosis Complex from Africa. Antimicrob Agents Chemother. 1997, 41 (7): 1601-1603.","journal-title":"Antimicrob Agents Chemother"},{"key":"3784_CR40","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/infdis\/173.1.196","volume":"173","author":"JM Musse","year":"1996","unstructured":"Musse JM, Kapur V, Williams DL, Kruswirth BN, van Soolingen D, van Embeden JDA: Characterization of catalase-peroxidase gene (Kat G) and innA locus in isoniazid-resistant and susceptible strains of Mycobacterium tuberculosis by automated sequencing: restricted array of mutations associated by drug resistance. J Infect Dis. 1996, 173: 196-202. 10.1093\/infdis\/173.1.196.","journal-title":"J Infect Dis"},{"key":"3784_CR41","first-page":"273","volume":"2","author":"J Walter","year":"1997","unstructured":"Walter J, Campbell A, Grumberg J, Pesold B, Schindzielorz A, Prior R: The Alzeimer\u2019s disease-associated presenilins are differentially phosphorylated proteins located predominately within the endoplasmic reticulum. J Mol Med. 1997, 2: 273-691.","journal-title":"J Mol Med"},{"key":"3784_CR42","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1128\/jcm.32.4.1095-1098.1994","volume":"32","author":"V Kapur","year":"1994","unstructured":"Kapur V, Li LL, Iordanescu S: Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase b subunit in rifampicin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol. 1994, 32: 1095-1098.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"3784_CR43","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1128\/JCM.40.10.3789-3792.2002","volume":"40","author":"T Tracevska","year":"2002","unstructured":"Tracevska T, Jansone I, Broka L, Baumanis V: Mutations in the rpoB and KatG genes leading to drug resistance in Mycobacterium tuberculosis in Latvia. J Clin Microbiol. 2002, 40 (10): 3789-3792. 10.1128\/JCM.40.10.3789-3792.2002.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"3784_CR44","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1128\/JCM.43.3.1390-1394.2005","volume":"43","author":"R Jou","year":"2005","unstructured":"Jou R, Chen HY, Chiang CY, Yu MC, Su IJ: Genetic diversity of multidrug-resistant Mycobacterium tuberculosis isolates and identification of 11 novel rpoB alleles in Taiwan. J Clin Microbiol. 2005, 43 (3): 1390-1394. 10.1128\/JCM.43.3.1390-1394.2005.","journal-title":"J Clin Microbiol"},{"key":"3784_CR45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1128\/JCM.36.1.20-23.1998","volume":"36","author":"P Matsiota-Bernard","year":"1998","unstructured":"Matsiota-Bernard P, Vrioni G, Marinis E: Characterization of rpoB mutations in rifampicin-resistant clinical Mycobacterium tuberculosis isolates from Greece. J Clin Microbiol. 1998, 36: 20-23.","journal-title":"J Clin Microbiol"},{"key":"3784_CR46","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1128\/AAC.40.4.1053","volume":"40","author":"H Ohno","year":"1996","unstructured":"Ohno H, Koga H, Kohno S: Relationship between rifampicin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob Agents Chemother. 1996, 40: 1053-1056.","journal-title":"Antimicrob Agents Chemother"},{"key":"3784_CR47","first-page":"321","volume":"4","author":"DA Cougant","year":"1999","unstructured":"Cougant DA, Sandven P, Eng J, Jeque JT, T\u00f8njum T: Detection of rifampicin resistance among isolates of Mycobacterium tuberculosis from Mozambique. Microb Drug Resist. 1999, 4: 321-326.","journal-title":"Microb Drug Resist"},{"key":"3784_CR48","volume-title":"World Health Organization Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs. WHO\/HTM\/TB\/2008.392","author":"World Health Organization","year":"2008","unstructured":"World Health Organization: World Health Organization Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs. WHO\/HTM\/TB\/2008.392. 2008, Geneva, Switzerland: World Health Organization, [http:\/\/whqlibdoc.who.int\/hq\/2008\/WHO_HTM_TB_2008.392_eng.pdf] (Accessed 30 April 2013)"},{"key":"3784_CR49","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1128\/JCM.37.10.3179-3186.1999","volume":"37","author":"GE Pfyffer","year":"1999","unstructured":"Pfyffer GE, Bonato DA, Ebrahimzadeh A, Gross W, Hotaling J: Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media. J Clin Microbiol. 1999, 37: 3179-3186.","journal-title":"J Clin Microbiol"},{"key":"3784_CR50","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1021\/cr0301088","volume":"105","author":"S Magnet","year":"2005","unstructured":"Magnet S, Blanchard JS: Molecular insights into aminoglycoside action and resistance. Chem Rev. 2005, 105: 477-498. 10.1021\/cr0301088.","journal-title":"Chem Rev"},{"key":"3784_CR51","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1159\/000386840","volume":"16","author":"L Trnka","year":"1970","unstructured":"Trnka L, Smith DW: Proteosynthetic activity of isolated ribosomes of Mycobacteria and its alteration by rifampicin and related tuberculostatic drugs. J Antibiot Chemother. 1970, 16: 369-379.","journal-title":"J Antibiot Chemother"},{"key":"3784_CR52","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1128\/AAC.00050-09","volume":"53","author":"S Feuerriegel","year":"2009","unstructured":"Feuerriegel S, Cox HS, Zarkua N, Karimovich HA, Braker K: Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment. Antimicrob Agents Chemother. 2009, 53: 3353-3356. 10.1128\/AAC.00050-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"3784_CR53","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1128\/AAC.39.3.769","volume":"39","author":"N Honore","year":"1995","unstructured":"Honore N, Marchal G, Cole ST: Novel mutation in 16S rRNA associated with streptomycin dependence in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1995, 39: 769-770. 10.1128\/AAC.39.3.769.","journal-title":"Antimicrob Agents Chemother"},{"key":"3784_CR54","first-page":"1412","volume":"10","author":"R Johnson","year":"2006","unstructured":"Johnson R, Warren R, Strauss OJ, Jordaan AM, Falmer AA, Beyers N: An outbreak of drug-resistant tuberculosis caused by a Beijing strain in the Western Cape, South Africa. Int J Tuberc Lung Dis. 2006, 10: 1412-1414.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"3784_CR55","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1128\/AAC.00851-09","volume":"53","author":"L Jugheli","year":"2009","unstructured":"Jugheli L, Bzekalava N, de Rijk P, Fissette K, Portaels F, Rigouts L: High level of cross resistance between kanamycin, amikacin and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene. Antimicrob Agents Chemother. 2009, 53 (12): 5064-5068. 10.1128\/AAC.00851-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"3784_CR56","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1128\/AAC.49.8.3192-3197.2005","volume":"49","author":"CE Maus","year":"2005","unstructured":"Maus CE, Plikaytis BB, Shinnick TM: Molecular analysis of crossresistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2005, 49: 3192-3197. 10.1128\/AAC.49.8.3192-3197.2005.","journal-title":"Antimicrob Agents Chemother"},{"key":"3784_CR57","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1128\/AAC.47.9.2971-2973.2003","volume":"47","author":"A Kr\u00fc\u00fcner","year":"2003","unstructured":"Kr\u00fc\u00fcner A, Jureen P, Levina K, Ghebremichael S, Hoffner S: Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2003, 47: 2971-2973. 10.1128\/AAC.47.9.2971-2973.2003.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-479.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-14-479\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-479","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-479.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T05:37:16Z","timestamp":1630561036000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-14-479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,4]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3784"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-14-479","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,4]]},"assertion":[{"value":"30 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"479"}}